Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Details
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_5551F9C73188
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
Journal
Haematologica
ISSN
1592-8721 (Electronic)
ISSN-L
0390-6078
Publication state
Published
Issued date
01/01/2023
Peer-reviewed
Oui
Volume
108
Number
1
Pages
234-239
Language
english
Notes
Publication types: Clinical Trial ; Letter
Publication Status: epublish
Publication Status: epublish
Abstract
Not available.
Keywords
Adult, Humans, Clinical Trials as Topic, Dexamethasone, Etoposide, Leukemia, Myeloid, Acute, Lymphohistiocytosis, Hemophagocytic/diagnosis, Lymphohistiocytosis, Hemophagocytic/drug therapy, Lymphohistiocytosis, Hemophagocytic/etiology, Pilot Projects
Pubmed
Web of science
Open Access
Yes
Create date
11/09/2022 9:19
Last modification date
08/07/2023 5:49
Usage data
